HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serotype-independent protection against pneumococcal infections elicited by intranasal immunization with ethanol-killed pneumococcal strain, SPY1.

Abstract
The 23-valent polysaccharide vaccine and the 7-valent pneumococcal conjugate vaccine are licensed vaccines that protect against pneumococcal infections worldwide. However, the incidence of pneumococcal diseases remains high in low-income countries. Whole-cell vaccines with high safety and strong immunogenicity may be a favorable choice. We previously obtained a capsule-deficient Streptococcus pneumoniae mutant named SPY1 derived from strain D39. As an attenuated live pneumococcal vaccine, intranasal immunization with SPY1 elicits broad serotype-independent protection against pneumococcal infection. In this study, for safety consideration, we inactivated SPY1 with 70% ethanol and intranasally immunized BALB/c mice with killed SPY1 plus cholera toxin adjuvant for four times. Results showed that intranasal immunization with inactivated SPY1 induced strong humoral and cellular immune responses. Intranasal immunization with inactivated SPY1 plus cholera toxin adjuvant elicited effective serotype-independent protection against the colonization of pneumococcal strains 19F and 4 as well as lethal infection of pneumococcal serotypes 2, 3, 14, and 6B. The protection rates provided by inactivated SPY1 against lethal pneumococcal infection were comparable to those of currently used polysaccharide vaccines. In addition, vaccine-specific B-cell and T-cell immune responses mediated the protection elicited by SPY1. In conclusion, the 70% ethanol-inactivated pneumococcal whole-cell vaccine SPY1 is a potentially safe and less complex vaccine strategy that offers broad protection against S. pneumoniae.
AuthorsXiuyu Xu, Jiangping Meng, Yiping Wang, Jie Zheng, Kaifeng Wu, Xuemei Zhang, Yibing Yin, Qun Zhang
JournalJournal of microbiology (Seoul, Korea) (J Microbiol) Vol. 52 Issue 4 Pg. 315-23 (Apr 2014) ISSN: 1976-3794 [Electronic] Korea (South)
PMID24682994 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adjuvants, Immunologic
  • Anti-Bacterial Agents
  • Antibodies, Bacterial
  • Pneumococcal Vaccines
  • Vaccines, Inactivated
  • Ethanol
  • Cholera Toxin
Topics
  • Adjuvants, Immunologic (administration & dosage)
  • Administration, Intranasal
  • Animals
  • Anti-Bacterial Agents (pharmacology)
  • Antibodies, Bacterial (blood)
  • Cholera Toxin (administration & dosage)
  • Cross Protection
  • Ethanol (pharmacology)
  • Immunization (methods)
  • Leukocytes, Mononuclear (immunology)
  • Mice, Inbred BALB C
  • Pneumococcal Infections (immunology, prevention & control)
  • Pneumococcal Vaccines (administration & dosage, adverse effects, immunology)
  • Streptococcus pneumoniae (immunology)
  • Survival Analysis
  • Vaccines, Inactivated (administration & dosage, adverse effects, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: